Tasly Pharma
Investors

Building durable value through science

Tasly combines disciplined execution with a robust innovation pipeline to create long-term value for shareholders and patients alike.

30+
Years of R&D excellence
40+
Countries reached
700+
Global patents
Governance & transparency

Governance & transparency

We are committed to strong corporate governance, ESG leadership and transparent, timely communication with the investment community.